BioSpace News Archive

Medical Licensing LLC has unveiled a dramatic solution to one of the most frustrating parts of a medical professional’s life – the licensing process.

pH-D® Feminine Health has revolutionized the feminine hygiene market.

Axcella Health Inc., (Nasdaq: AXLA) (“Axcella or the Company”) a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced liver program progress updates regarding the development of AXA1125 and AXA1957.

Nordic Nanovector ASA announces that it has signed a long-term global supply agreement with a subsidiary of ITM Isotopen Technologien München AG, Isotope Technologies Garching GmbH to ensure the supply of high quality, no-carrier-added Lutetium-177, a key component of Betalutin® for R&D, clinical and commercial uses.

ITM Isotopen Technologien München AG announced that ITM´s subsidiary, ITG Isotope Technologies Garching GmbH and Nordic Nanovector ASA have signed long-term global supply agreements for the medical radioisotope no-carrier-added Lutetium-177 EndolucinBeta® to support R&D, clinical and commercial supply of Betalutin®.

Atlas Venture announced the launch of Korro Bio, Inc., a new company created to lead the rapidly advancing field of RNA editing.

Joint Cancer Program in Boston First in New England to Offer MRI-Guided Radiation Therapy

Nevakar Inc. announced that it has entered into a $17.5 million product financing agreement with an affiliate of H.I.G.

For the first time, SilverSummit Healthplan will offer a Medicare Advantage HMO plan.

DURECT Corporation (Nasdaq: DRRX) today announced that it has completed enrollment in its Phase 2a clinical trial of topical DUR-928 in patients with mild to moderate plaque psoriasis